Growth Metrics

Innoviva (INVA) Prepaid Assets (2010 - 2026)

Innoviva posted quarterly Prepaid Assets of $24.8 million for Q1 2026, up 7836.74% year-on-year from $313000.0 in Q1 2025, and up 1417.53% on a QoQ basis from $1.6 million in Q4 2025.

Innoviva (INVA) has 17 years of Prepaid Assets data on file, last reported at $24.8 million in Q1 2026.

  • For the quarter ending Q1 2026, Prepaid Assets rose 7836.74% year-over-year to $24.8 million; the trailing twelve-month figure through Mar 2026 stood at $24.8 million (up 7836.74% YoY), and the FY2025 full-year result was $1.6 million, down 92.23% from the prior year.
  • Prepaid Assets for Q1 2026 stood at $24.8 million, up from $1.6 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $24.8 million in Q1 2026 and bottomed at $171000.0 in Q3 2025.
  • The 5-year median for Prepaid Assets is $3.0 million (2024), against an average of $8.2 million.
  • The widest annual swing landed in 2025, when Prepaid Assets sank 92.23%; it then jumped 7836.74% in 2026.
  • A 5-year view of Prepaid Assets shows it stood at $2.9 million in 2022, then surged by 45.38% to $4.3 million in 2023, then surged by 393.97% to $21.1 million in 2024, then tumbled by 92.23% to $1.6 million in 2025, then jumped by 1417.53% to $24.8 million in 2026.
  • The last three Prepaid Assets figures came in at $24.8 million (Q1 2026), $1.6 million (Q4 2025), and $171000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Innoviva 1.60 Bn 992.84 Mn 75.83 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 24.84 Mn
Dec 31, 2025 1.64 Mn
Sep 30, 2025 171,000.00
Jun 30, 2025 16.61 Mn
Mar 31, 2025 313,000.00
Dec 31, 2024 21.06 Mn
Sep 30, 2024 2.05 Mn
Jun 30, 2024 2.15 Mn
Mar 31, 2024 2.99 Mn
Dec 31, 2023 4.26 Mn
Sep 30, 2023 1.99 Mn
Jun 30, 2023 20.54 Mn
Mar 31, 2023 24.12 Mn
Dec 31, 2022 2.93 Mn
Sep 30, 2022 7.93 Mn
Jun 30, 2022 3.95 Mn
Mar 31, 2022 1.93 Mn
Dec 31, 2021 70,000.00
Sep 30, 2021 542,000.00
Jun 30, 2021 734,000.00
Mar 31, 2021 1.07 Mn
Dec 31, 2020 1.64 Mn
Sep 30, 2020 698,000.00
Jun 30, 2020 645,000.00
Mar 31, 2020 822,000.00
Dec 31, 2019 962,000.00
Sep 30, 2019 383,000.00
Jun 30, 2019 459,000.00
Mar 31, 2019 702,000.00
Dec 31, 2018 849,000.00
Sep 30, 2018 513,000.00
Jun 30, 2018 576,000.00
Mar 31, 2018 950,000.00
Dec 31, 2017 754,000.00
Sep 30, 2017 439,000.00
Jun 30, 2017 642,000.00
Mar 31, 2017 880,000.00
Dec 31, 2016 766,000.00
Sep 30, 2016 534,000.00
Jun 30, 2016 738,000.00
Mar 31, 2016 975,000.00
Dec 31, 2015 814,000.00
Sep 30, 2015 615,000.00
Jun 30, 2015 697,000.00
Mar 31, 2015 1.01 Mn
Dec 31, 2014 1.13 Mn
Sep 30, 2014 748,000.00
Jun 30, 2014 982,000.00
Mar 31, 2014 6.39 Mn
Dec 31, 2013 4.29 Mn
Sep 30, 2013 4.07 Mn
Jun 30, 2013 3.61 Mn
Mar 31, 2013 5.19 Mn
Dec 31, 2012 4.07 Mn
Sep 30, 2012 3.77 Mn
Jun 30, 2012 3.40 Mn
Mar 31, 2012 3.90 Mn
Dec 31, 2011 3.53 Mn
Sep 30, 2011 3.85 Mn
Jun 30, 2011 4.51 Mn
Dec 31, 2010 6.00 Mn